Join distinguished international faculty members as they discuss the most recent science and clinical guidance for treatment of atrial fibrillation, including the role of antiarrhythmic drugs (AADs).

Learn to implement new guideline-driven management strategies for atrial fibrillation (AFib), promoting optimal patient outcomes and quality of care.

Learn to identify essential clinical and procedural considerations when performing a percutaneous coronary intervention (PCI) on a post-TAVR patient.

Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. Access resources and education to address knowledge gaps in the identification and appropriately managing HCM to reduce the burden of disease progression.

Build competence in timely detection and diagnosis of cardiac amyloidosis, recognize findings suggestive of this condition and learn to select appropriate testing, and review new treatment options that have a meaningful impact on quality of life and life expectancy for these patients.

Explore the stages of heart failure (HF) where Baroreflex Activation Therapy (BAT) is beneficial: early intervention advantages, patient selection criteria, and synergy between devices and medications in HF treatment.

Learn about the prevalence of hypertension in women and its relationship with menopausal symptoms as a woman ages to explore up-to-date diagnostic approaches and technologies to support blood pressure monitoring and timely, effective care.

Understand the role of hs-CRP as a biomarker in assessing inflammation and cardiovascular disease (CVD) risk, the importance of screening, and the value of an interprofessional approach to enhance patient outcomes and maintain cardiovascular health.

Learn key terminology related to lipoprotein(a) (Lp[a]) and recognize the importance of testing for elevated Lp(a) levels as a risk factor for ASCVD, as well as distinguish Lp(a)'s significance from general lipids in cardiovascular health.

Learn about evolving role of bempedoic acid and its utilization in the statin intolerant patient, including clinical trial data, how to identify patients that would benefit from this agent and how to integrate it into your practice.

Learn contemporary approaches to the management of hypertension, the leading cause of cardiovascular disease, premature death, and disability-adjusted life years in the world.

Improve detection and diagnosis of Familial Hypercholesterolemia (FH) and increase familiarity with the new treatment options available to the cardiovascular community.

Learn best practices and emerging science across practice-changing topics in care cardiac arrhythmias, cardiovascular disease prevention, heart failure and cardiomyopathies, and vascular diseases.

Palliative care is an important knowledge and skill set for all members of the Cardiovascular Team. This educational activity aims to provide cardiovascular clinicians with training to increase comfort and skill in advance care planning and end of life care.

These educational activities are designed to inspire and achieve a culture of health where every person reaches their full cardiovascular health potential.

Learn about the superiority of PET over SPECT for assessment of ischemic heart disease and how to integrate PET imaging into a multimodality approach.